Moderna, Inc.: Moderna Announces Swissmedic Authorizes Booster Dose of Moderna's COVID-19 Vaccine
Authorization granted for particularly vulnerable individuals 12 years of age and older Swissmedic also authorized a third dose for individuals 12 years of age and older with a weakened immune system